The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Wells William Mcdowall since 2010.
The trader's CIK number is 1476860.
At the time of the last reporting, Wells William Mcdowall was the Director of Acadia Pharmaceuticals Inc. (stock ticker symbol ACAD).
Also see all insider trading activities at Acadia Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2010 | VRX | 0 | $0 | 882,951 | $23,984,542 | 394,640 | $4,521,080 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | ACAD | 0 | $0 | 60,000 | $1,588,210 | 60,000 | $85,199 |
1. Bausch Health Companies Inc. (VRX)
2. Acadia Pharmaceuticals Inc (ACAD)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2010-12-07 | VRX | Option Ex | 19,540 | .00 | 0 |
| 2010-12-06 | VRX | Sale | 490,461 | 28.13 | 13,796,667 |
| 2010-12-07 | VRX | Sale | 17,390 | 28.05 | 487,789 |
| 2010-11-09 | VRX | Sale | 375,100 | 25.86 | 9,700,086 |
| 2010-11-09 | VRX | Option Ex | 375,100 | 12.05 | 4,521,080 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-11-21 | ACAD | Option Ex | 5,810 | 1.36 | 7,901 |
| 2014-11-21 | ACAD | Sale | 5,810 | 29.00 | 168,490 |
| 2014-09-12 | ACAD | Option Ex | 9,190 | 1.36 | 12,498 |
| 2014-09-12 | ACAD | Sale | 9,190 | 29.15 | 267,870 |
| 2014-09-02 | ACAD | Sale | 30,000 | 26.88 | 806,400 |
| 2014-09-02 | ACAD | Option Ex | 30,000 | 1.36 | 40,800 |
| 2014-06-09 | ACAD | Option Ex | 15,000 | 1.60 | 24,000 |
| 2014-06-09 | ACAD | Sale | 15,000 | 23.03 | 345,450 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wells William Mcdowall (Director of Acadia Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.